IPOPLUS

239.61

+1.2 +0.50%

18 Jun 2026

NSE Listed · Pharmaceuticals

Sun Pharma Adv.Res.Co.Ltd (SPARC)

Volume: 3,05,847Avg Vol 1W: 2,72,156Avg Vol 1M: 6,18,45052W Range:108248.75
₹239.61 0.50%
Market Cap₹7,250 Cr
Current Price₹239.61
Previous Close₹238.41
High / Low (52w)₹248.75 / ₹108
Volume3,05,847
Avg Vol (1W)2,72,156
Avg Vol (1M)6,18,450
Stock P/E
Book Value₹41.26
Dividend Yield0%
ROE116.01%
ROA71.55%
Revenue (TTM)
Revenue Growth-5%
Profit Margin39.67%
Total Debt₹100 Cr
Shares Outstanding32 Cr
Face Value₹1
EPS (TTM)₹54.27
P/B5.56
Debt / Equity0.42
50 DMA₹176.07
200 DMA₹141.94
Day change+0.50%
Price Chart
239.61 81.18% · 1Y
24010912.1Cr
2025-10-01
2026-06-16

20-day avg volume: 6.7L shares

Pros
  • Healthy return on equity of 116.0%.
  • Company is almost debt-free.
Cons
  • Revenue fell 30% YoY.
  • Company is loss-making at the latest annual result.
Quarterly Results
MetricMar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023Sept 2023Jun 2023Mar 2023Dec 2022Sept 2022Jun 2022Mar 2022Dec 2021Sept 2021Jun 2021Mar 2021Dec 2020Sept 2020Jun 2020Mar 2020
Revenue₹1,853 Cr₹8 Cr₹8 Cr₹10 Cr₹27 Cr₹15 Cr₹13 Cr₹17 Cr₹17 Cr₹14 Cr₹21 Cr₹24 Cr₹48 Cr₹131 Cr₹32 Cr₹28 Cr₹25 Cr₹62 Cr₹28 Cr₹22 Cr₹28 Cr₹22 Cr₹18 Cr₹185 Cr₹23 Cr
EBITDA₹1,773 Cr₹-59 Cr₹-68 Cr₹-46 Cr₹-56 Cr₹-77 Cr₹-106 Cr₹-95 Cr₹-104 Cr₹-99 Cr₹-86 Cr₹-95 Cr₹-82 Cr₹13 Cr₹-66 Cr₹-81 Cr₹-69 Cr₹-14 Cr₹-52 Cr₹-56 Cr₹-53 Cr₹-64 Cr₹-82 Cr₹59 Cr₹-98 Cr
Net Profit₹1,761 Cr₹-80 Cr₹-76 Cr₹-52 Cr₹-60 Cr₹-80 Cr₹-107 Cr₹-96 Cr₹-106 Cr₹-100 Cr₹-86 Cr₹-95 Cr₹-82 Cr₹10 Cr₹-68 Cr₹-82 Cr₹-71 Cr₹-16 Cr₹-55 Cr₹-61 Cr₹-57 Cr₹-68 Cr₹-83 Cr₹57 Cr₹-100 Cr
EPS54.27-2.48-2.34-1.6-1.84-2.45-3.31-2.96-3.26-3.07-2.66-2.94-2.550.35-2.52-3.03-2.69-0.6-2.09-2.34-2.16-2.58-3.192.16-3.8
Profit & Loss (Annual)
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Revenue₹74 Cr₹105 Cr₹250 Cr₹144 Cr₹258 Cr₹87 Cr
EBITDA₹-334 Cr₹-385 Cr₹-215 Cr₹-190 Cr₹-140 Cr₹-310 Cr
Net Profit₹-343 Cr₹-387 Cr₹-223 Cr₹-203 Cr₹-151 Cr₹-312 Cr
EPS-10.55-11.93-7.82-7.73-5.77-11.92
Balance Sheet
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Total Assets₹336 Cr₹515 Cr₹830 Cr₹280 Cr₹230 Cr₹273 Cr
Total Liabilities₹552 Cr₹389 Cr₹317 Cr₹249 Cr₹398 Cr₹291 Cr
Equity₹-217 Cr₹126 Cr₹513 Cr₹31 Cr₹-168 Cr₹-19 Cr
Total Debt₹100 Cr₹0 Cr₹0 Cr₹0 Cr₹113 Cr₹6 Cr
Cash Flow
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Operating₹-369 Cr₹-425 Cr₹-74 Cr₹-213 Cr₹-150 Cr
Investing₹158 Cr₹392 Cr₹-548 Cr₹-29 Cr₹2 Cr
Financing₹199 Cr₹42 Cr₹617 Cr₹229 Cr₹159 Cr
Free Cash Flow₹-369 Cr₹-425 Cr₹-74 Cr₹-213 Cr₹-150 Cr
Shareholding
Promoter 65.67% Institutions 2.57% Public 31.76%

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search